author_facet James, R.
Blanco, C.
Farina, C.
James, R.
Blanco, C.
Farina, C.
author James, R.
Blanco, C.
Farina, C.
spellingShingle James, R.
Blanco, C.
Farina, C.
European Journal of Cancer Supplements
271 Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advance colorectal cancer
Cancer Research
Oncology
author_sort james, r.
spelling James, R. Blanco, C. Farina, C. 1359-6349 Elsevier BV Cancer Research Oncology http://dx.doi.org/10.1016/s1359-6349(03)90304-1 271 Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advance colorectal cancer European Journal of Cancer Supplements
doi_str_mv 10.1016/s1359-6349(03)90304-1
facet_avail Online
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMTM1OS02MzQ5KDAzKTkwMzA0LTE
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMTM1OS02MzQ5KDAzKTkwMzA0LTE
institution DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
imprint Elsevier BV, 2003
imprint_str_mv Elsevier BV, 2003
issn 1359-6349
issn_str_mv 1359-6349
language English
mega_collection Elsevier BV (CrossRef)
match_str james2003271savingsinstafftimeasaresultofswitchingfromdegramonttooralcapecitabineforpatientswithadvancecolorectalcancer
publishDateSort 2003
publisher Elsevier BV
recordtype ai
record_format ai
series European Journal of Cancer Supplements
source_id 49
title 271 Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advance colorectal cancer
title_unstemmed 271 Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advance colorectal cancer
title_full 271 Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advance colorectal cancer
title_fullStr 271 Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advance colorectal cancer
title_full_unstemmed 271 Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advance colorectal cancer
title_short 271 Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advance colorectal cancer
title_sort 271 savings in staff time as a result of switching from de gramont to oral capecitabine for patients with advance colorectal cancer
topic Cancer Research
Oncology
url http://dx.doi.org/10.1016/s1359-6349(03)90304-1
publishDate 2003
physical S83
description
container_issue 5
container_start_page 0
container_title European Journal of Cancer Supplements
container_volume 1
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792330917746835458
geogr_code not assigned
last_indexed 2024-03-01T13:30:45.153Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=271+Savings+in+staff+time+as+a+result+of+switching+from+De+Gramont+to+oral+capecitabine+for+patients+with+advance+colorectal+cancer&rft.date=2003-09-01&genre=article&issn=1359-6349&volume=1&issue=5&pages=S83&jtitle=European+Journal+of+Cancer+Supplements&atitle=271+Savings+in+staff+time+as+a+result+of+switching+from+De+Gramont+to+oral+capecitabine+for+patients+with+advance+colorectal+cancer&aulast=Farina&aufirst=C.&rft_id=info%3Adoi%2F10.1016%2Fs1359-6349%2803%2990304-1&rft.language%5B0%5D=eng
SOLR
_version_ 1792330917746835458
author James, R., Blanco, C., Farina, C.
author_facet James, R., Blanco, C., Farina, C., James, R., Blanco, C., Farina, C.
author_sort james, r.
container_issue 5
container_start_page 0
container_title European Journal of Cancer Supplements
container_volume 1
description
doi_str_mv 10.1016/s1359-6349(03)90304-1
facet_avail Online
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMTM1OS02MzQ5KDAzKTkwMzA0LTE
imprint Elsevier BV, 2003
imprint_str_mv Elsevier BV, 2003
institution DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1
issn 1359-6349
issn_str_mv 1359-6349
language English
last_indexed 2024-03-01T13:30:45.153Z
match_str james2003271savingsinstafftimeasaresultofswitchingfromdegramonttooralcapecitabineforpatientswithadvancecolorectalcancer
mega_collection Elsevier BV (CrossRef)
physical S83
publishDate 2003
publishDateSort 2003
publisher Elsevier BV
record_format ai
recordtype ai
series European Journal of Cancer Supplements
source_id 49
spelling James, R. Blanco, C. Farina, C. 1359-6349 Elsevier BV Cancer Research Oncology http://dx.doi.org/10.1016/s1359-6349(03)90304-1 271 Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advance colorectal cancer European Journal of Cancer Supplements
spellingShingle James, R., Blanco, C., Farina, C., European Journal of Cancer Supplements, 271 Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advance colorectal cancer, Cancer Research, Oncology
title 271 Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advance colorectal cancer
title_full 271 Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advance colorectal cancer
title_fullStr 271 Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advance colorectal cancer
title_full_unstemmed 271 Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advance colorectal cancer
title_short 271 Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advance colorectal cancer
title_sort 271 savings in staff time as a result of switching from de gramont to oral capecitabine for patients with advance colorectal cancer
title_unstemmed 271 Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advance colorectal cancer
topic Cancer Research, Oncology
url http://dx.doi.org/10.1016/s1359-6349(03)90304-1